IM Cannabis Corp.

IMCC • Drug Manufacturers - Specialty & Generic

$1.40

▼ -0.10 (-6.67%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL DE MAYOR RIESGOPrecauciónConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Conviene actuar con cautela. Los ratios recientes muestran debilidades que pueden limitar el retorno si los fundamentales no mejoran.

Capitalización

$13.16M

Crecimiento

-11.5%

Flujo de caja

1/5

Tendencia

Volatile

Evidencia

Flujo de caja libre positivo · 1.11Liquidez débil · 0.67Rentabilidad débil

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 19 ago 2026, 12:24 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$1.40

Change-6.67%

Shares Out9.27M

Market Cap$13.16M

52W Range0.09 - 2.61

Beta2.06

P/E-6.22

P/S6.53

P/B-8.19

P/FCF-100.11

EV/Sales2.66

EV/EBITDA-19.61

Price$1.40

Change-6.67%

Shares Out9.27M

Market Cap$13.16M

52W Range0.09 - 2.61

Beta2.06

P/E-6.22

P/S6.53

P/B-8.19

P/FCF-100.11

EV/Sales2.66

EV/EBITDA-19.61

EV/FCF-40.82

Earnings Yield-4.02%

FCF Yield-1.00%

Dividend Yield0.00%

Gross Margin17.70%

Oper. Margin-21.17%

Profit Margin-20.68%

Debt/Eq-18.96

Current Ratio0.67

Quick Ratio0.54

Revenue 5Y-11.46%

Volume1.13M

Avg Volume4.37M

EPS Surprise-0.95

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

22/100

Fortaleza financiera

Deuda, caja, estabilidad

20/100

Potencial de crecimiento

Ingresos y expansión

62/100

Atractivo del precio

Barata o cara hoy

95/100

Por qué este puntaje▼

Flujo de caja libre positivo · 1.11Liquidez débil · 0.67Rentabilidad débil

Analyst view

Analyst sentiment and price target

IMCC

Analyst sentiment

Based on 1 analyst votes · 2026-10-20

100/100

Bullish

Hold

Bearish

Resumen de la compañía

IPO: 5/20/2020

Industria: Drug Manufacturers - Specialty & Generic

P/B i: -8.19

Deuda / Patrimonio i: -18.96

Margen operativo: -21.17%

Margen neto: -20.68%

ROE i: -

ROIC: -

Salud financiera

Puntaje4 / 20

Deuda / Patrimonio: -18.96

Ratio corriente: 0.67

Ratio rápido: 0.54

Estado: HighRisk

Advertencias

Weak Liquidity
Weak quick ratio

🧾

No hay actividad interna

No hay transacciones internas recientes disponibles.

Sobre la compañía

IM Cannabis Corp.

IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Fuente - Link

Competidores

AKAN FLGC GRI JAGX MOVE NAOV NDRA RDHL SHPH VERO

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet

Transaction Expected to Result in an Improvement of Approximately C$3 Million in Shareholders' Equity VANCOUVER, BC and GLIL YAM, Israel, Sept. 29, 2026 /PRNewswire/ -- IM Cannabis Corp. (the "Company") (NASDAQ: IMCC), today announced that, further to its press releases dated June 18, 2026 and August 17, 2026, it has completed the previously announced transaction contemplated by the definitive share purchase agreement dated August 16, 2026 (the "Share Purchase Agreement") among the Company, Slil.com Holding Ltd.

PRNewsWire

IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares

VANCOUVER, BC and GLIL YAM, Israel, Sept. 24, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of its previously announced registered direct offering (the "Offering"), pursuant to which the Company sold and issued 655,000 common shares, no par value per share (the "Common Shares"), to certain accredited investors at a purchase price of US$2.00 per Common Share, resulting in aggregate gross proceeds to the Company of US$1.31 million, before deducting offering expenses.

PRNewsWire

IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement

VANCOUVER and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that on September 23, 2026, it received written notice from Nasdaq Stock Market LLC ("Nasdaq"), indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.

PRNewsWire

IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares

VANCOUVER, BC and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has entered into securities purchase agreements with certain accredited investors for the purchase and sale of 655,000 common shares, no par value per share, at a purchase price of US$2.00 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately US$1.31 million at closing before offering expenses.

PRNewsWire

IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market

The Company has entered a non-binding Letter of Intent to acquire control of Space Defense Innovations LLC, which is engaged in distributing BlueBird Aero Systems' advanced tactical UAS and unique Hybrid Fixed-Wing VTOL-UAS platforms in Europe TORONTO and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), today announced that it has entered into a non-binding Letter of Intent (the "LOI") to acquire 51% of the issued and outstanding equity securities of Space Defense Innovations LLC, a Polish limited liability company ("SDI"), on a fully diluted basis.

PRNewsWire

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-03-30	0.08596	-0.86	-0.94596
2025-11-13	-0.02313	-0.54	-0.51687
2025-08-12	-0.13668	-0.07	0.06668
2025-05-15	-0.25468	0.06	0.31468
2025-03-31	-0.39	-0.23	0.16
2024-11-14	-0.7	-0.3	0.4
2024-08-14	-0.84	-0.17	0.67
2024-05-08	-0.96	-0.96	0
2024-03-28	-0.96	-1.08	-0.12
2023-11-13	-0.96	-0.72	0.24
2023-08-14	-0.78	-1.14	-0.36
2023-05-15	-1.2	0.12	1.32